Mumps Therapeutics - Pipeline Analysis, Clinical Trials & Results

Mumps is a transmissible disease caused by the mumps virus and is characterized by swelling of glands in neck and face. Some of the symptoms of this disease are headache, fever, tiredness, loss of appetite, and muscle ache. Request to Get Sample Pages at:  https://www.pharmaproff.com/request-sample/1067 The...

Read More

Middle East Respiratory Syndrome (MERS) Therapeutics Pipeline Analysis

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Coronaviruses are a type of viruses that affect the respiratory tract of mammals, including humans. Human coronaviruses usually cause mild to moderate cold-like illnesses....

Read More

Klebsiella Infections Therapeutics Pipeline Analysis, Clinical Trials & Results

Klebsiella infections include different types of infections like bloodstream infections; pneumonia; wound or surgical site infections; and meningitis, caused by the Klebsiella bacteria. The symptoms associated with these infections are high fevers, chills, cough, and shortness...

Read More

Impetigo Therapeutics: Drug Development Pipeline Analysis

Impetigo is a common bacterial infection caused by different kinds of bacteria, including streptococcus and staphylococcus. It is a contagious disease and begins with appearance of red sores on any part of the body, which eventually changes to blisters on the body. Request to...

Read More

Ischemic Stroke Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents

Ischemic stroke develops due to an obstruction within a blood vessel which supply blood to the brain. The underlying condition for this type of obstruction is atherosclerosis, which is characterized by fatty deposition or plaque build-up in the blood vessels. Request...

Read More

Infantile Spasm Therapeutics - Pipeline Analysis, Clinical Trials and Results

Infantile spasm, also known as West syndrome, is a rare type of seizure disorder which is characterized by sudden stiffening of the body, legs and arms, and forward bending of head. It is diagnosed by physical examination, neurological examination, electroencephalography...

Read More

Hyperalgesia Therapeutics - Pipeline Analysis, Clinical Trials & Results

Hyperalgesia is a medical condition in which a person develops an increased sensitivity towards pain. There are several nerve pathways in the body where signals can start miscommunication with each other, resulting in hyperalgesia. Request to Get Free Sample Pages at:  https://www.pharmaproff.com/request-sample/1100 Hyperalgesia can...

Read More

Essential Tremor Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations

Essential tremor, a nerve disorder, is characterized by involuntary tremors or shaking in different parts of the body. The most common affected areas are head, arms, hands, larynx, chin and tongue. This disease creates difficulties in daily activities such as eating, writing...

Read More

Dravet Syndrome Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations

Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor...

Read More

Dementia Therapeutics - Pipeline Analysis, Clinical Trials & Results

Dementia is a group of neurological disorders which is characterized by impaired intellectual functioning. People having dementia generally lose the ability to maintain emotional control and solve the problems. Dementia can lead to the number of cognitive and psychological...

Read More

Complex Regional Pain Syndrome (CRPS) Therapeutics - Pipeline Analysis

Complex regional pain syndrome (CRPS) is a type of chronic pain that affects one limb of the body (hand, leg, arm, or foot). The condition generally arises due to severe injuries or malfunctioning of central and peripheral nervous systems. Request to Get Free Sample Pages...

Read More

Cognitive Impairment Therapeutics Pipeline Analysis | Stages, Drug Class, Company Profile

Cognitive impairment is a medical condition in which people lose their cognitive capabilities such as thinking skills and memory. People having cognitive impairment are at high risk of developing dementia or Alzheimer’s disease.  Cognitive impairment that affects...

Read More

Cerebral Palsy Therapeutics - Pipeline Analysis | Clinical Trials & Results

In cerebral palsy, the term cerebral refers to brain and palsy refers to the loss or impairment of motor function. Cerebral palsy is a group of neurological disorders that appear in infancy or early childhood, and permanently affect body movement and muscle coordination....

Read More

Pharmacological Therapies for Asperger Syndrome

Asperger syndrome is an autism spectrum disorder characterized by impaired communication skills and repetitive thoughts or behavior. Symptoms associated with the Asperger syndrome are lack of speech recognition skills, dislike for routine changes, avoidance of eye contacts,...

Read More

Von Hippel-Lindau Syndrome Therapeutics - Pipeline Analysis 2020, Clinical Trials & Results

Von Hippel-Lindau syndrome is a genetic disorder characterized by formation of cysts and tumors in different parts of the body. The symptoms associated with the disease depends upon the location of tumor. However, gait disturbance, dizziness, weakness of the limbs, deafness,...

Read More

Focal Segmental Glomerulosclerosis (FSGS) Therapeutics - Pipeline Analysis 2020, Clinical Trials & Results

Focal segmental glomerulosclerosis (FSGS) is a glomerular disease, which is characterized by scarring or sclerosis in the kidney. Scarring damages the limited number of glomeruli in the initial stages. It is more common in males than in females, and is very common in African...

Read More

Tic Disorder Therapeutics - Pipeline Analysis 2020, Clinical Trials & Results, Patents, Designations, Collaborations

Tic disorder is a type of mental disorder, characterized by sudden and nonrhythmic movements. According to the World Health Organisation (WHO), this disease can be categorized into five types; transient, combined vocal and multiple motor, unspecified, and chronic motor tic...

Read More

Spasticity Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations, Collaborations

Spasticity is a condition in which certain muscles are continuously contracted. The constant muscle contraction causes stiffness or tightness of the muscles and can interfere with normal movement, speech and gait in a patient. Access Detailed Report Summary: https://www.pharmaproff.com/report/spasticity-therapeutics-pipeline-analysis Spasticity is...

Read More

Polymyalgia Rheumatica Therapeutics - Pipeline Analysis, Clinical Trials & Results

Polymyalgia rheumatica is an inflammatory disorder which causes stiffness and aching, and usually affects adults over the age of 50 years. This disease affects women somewhat more than men. The cause of polymyalgia rheumatica is unknown. Access Detailed Report Summary: https://www.pharmaproff.com/report/polymyalgia-rheumatica-therapeutics-pipeline-analysis Polymyalgia...

Read More

Tagraxofusp - API Insight by Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Tagraxofusp was developed...

Read More

Androgenetic Alopecia Therapeutics Pipeline Analysis by Stages, Drug Class, Company Profile, Phase of Development, Clinical Trial & Discovery Stage Insights

Androgenetic Alopecia Therapeutics – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2019 published by Pharma Proff, androgenetic alopecia therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates. Androgenetic Alopecia...

Read More

Adrenoleukodystrophy (ALD) Therapeutics Pipeline Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy and Regulatory Landscape

Adrenoleukodystrophy (ALD) Therapeutics Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff, ALD currently exhibits a proliferating pipeline with 10 therapeutic candidates. ALD Pipeline...

Read More